Evaluation of commercial molecular diagnostic methods for detection and determination of macrolide resistance in Mycoplasma pneumoniae
SM Leal Jr, AH Totten, L Xiao, DM Crabb… - Journal of clinical …, 2020 - Am Soc Microbiol
We evaluated six commercial molecular tests targeting Mycoplasma pneumoniae, namely,
the BioFire FilmArray respiratory panel (RP), the Meridian Alethia Mycoplasma Direct, the …
the BioFire FilmArray respiratory panel (RP), the Meridian Alethia Mycoplasma Direct, the …
An accurate and convenient method for Mycoplasma pneumoniae via one-step LAMP-CRISPR/Cas12b detection platform
T Liu, Q Liu, F Chen, Y Shi, G Maimaiti… - Frontiers in Cellular …, 2024 - frontiersin.org
Introduction Mycoplasma pneumoniae (MP) is the major cause of respiratory infections that
threaten the health of children and adolescents worldwide. Therefore, an early, simple, and …
threaten the health of children and adolescents worldwide. Therefore, an early, simple, and …
Mycoplasma pneumoniae infection in adults
SG Baum, TM File Jr, S Bond - UpToDate, Basow, DS (Ed), UpToDate …, 2012 - uptodate.com
Mycoplasma pneumoniae is one of the smallest free-living organisms and a common
bacterial respiratory tract pathogen. Upper respiratory tract infections and acute bronchitis …
bacterial respiratory tract pathogen. Upper respiratory tract infections and acute bronchitis …
Mycoplasma pneumoniae infection in children
JG Vallejo - Uptodate January, 2020 - uptodate.com
Mycoplasma pneumoniae is one of the few species of Mycoplasma that frequently cause
infection in humans. M. pneumoniae predominantly causes respiratory tract infection but has …
infection in humans. M. pneumoniae predominantly causes respiratory tract infection but has …